Stereotactic ablative radiotherapy (SABR) for pelvic nodal oligorecurrence in prostate cancer.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published Date: Oct 3, 2024

Abstract

BACKGROUND: This study evaluated the clinical outcomes of stereotactic ablative radiotherapy (SABR) in the treatment of oligometastatic pelvic node prostate cancer to delay androgen deprivation therapy (ADT).

Authors

  • Marta Lopez-Valcarcel
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Francisco J Valcarcel
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Joaquin Velasco
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Irma Zapata
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Ruth Rodriguez
    Medical Physics, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Jorge Cardona
    Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Beatriz Gil
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Sofia Cordoba
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Raquel Benlloch
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Maria Hernandez
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Sofia Santana
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Ricardo Gomez
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Cristina De la Fuente
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • M Isabel Garcia-Berrocal
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Carlos Regueiro
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Jesus Romero
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals